Page last updated: 2024-10-26

valproic acid and Ataxia of Gait

valproic acid has been researched along with Ataxia of Gait in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"Hyperammonemic encephalopathy is a rare and serious adverse reaction to valproate."1.56Valproate-induced hyperammonemic encephalopathy: a case report. ( Shah, S; Vieux, U; Wang, R, 2020)
"Opsoclonus-myoclonus-ataxia syndrome (OMS) is a rare neurological disorder of probably autoimmune origin."1.35Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase. ( Alexiou, E; Gekas, G; Markakis, I; Rombos, A; Xifaras, M, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Shah, S1
Wang, R1
Vieux, U1
Markakis, I1
Alexiou, E1
Xifaras, M1
Gekas, G1
Rombos, A1

Other Studies

2 other studies available for valproic acid and Ataxia of Gait

ArticleYear
Valproate-induced hyperammonemic encephalopathy: a case report.
    Journal of medical case reports, 2020, Jan-25, Volume: 14, Issue:1

    Topics: Antimanic Agents; Brain Diseases; Confusion; Female; Gait Ataxia; Humans; Hyperammonemia; Middle Age

2020
Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
    Clinical neurology and neurosurgery, 2008, Volume: 110, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Anticonvulsants; Autoantibodies; Autoimmune Diseases; Female; Gait

2008